Positive clinical outcomes in adeno-associated virus (AAV)-mediated retinal gene therapy have often been attributed to the low immunogenicity of AAVs and immune privilege of the eye. However. several recent studies have shown potential for inflammatory responses. The current understanding of the factors contributing to inflammation. https://www.marketingjeunesse.com/product-category/shaping-spray/